Find the people, expertise, and partnerships that can move your research forward. Case CCC's six interdisciplinary research programs connect investigators across three institutions who share scientific interests and complementary expertise.
Whether you're beginning a new project, expanding your research team, or seeking collaborators for a grant or clinical study, our programs make it easier to discover potential partners, exchange ideas, and build the relationships that lead to new discoveries.
Cancer Genomics and Epigenomics
Program Leaders: Abhishek Chakraborty, PhD, Fulai Jin, PhD, and Zhenghe John Wang, PhD
Uniting experts in cancer genetics and epigenetics to uncover the molecular changes that drive cancer and transform those discoveries into new approaches for prevention, diagnosis, and treatment.
Cancer Imaging
Program Leaders: James P. Basilion, PhD, Agata Exner, PhD, and Zhenghong Lee, PhD
Integrating imaging, engineering, and cancer biology to create innovative technologies that enhance cancer diagnosis and inform patient care.
Developmental Therapeutics
Program Leaders: John J. Letterio, MD, Jordan Winter, MD, and Jennifer Yu, MD, PhD
Bridging laboratory discoveries and clinical research to advance new treatments for cancer and improve patient outcomes.
Immune Oncology
Program Leaders: Alex Huang, MD, PhD, and David Wald, MD, PhD
Harnessing the power of the immune system to develop more effective cancer therapies and overcome treatment resistance.
Molecular Oncology
Program Leaders: Justin Lathia, PhD, and Boaz Tirosh, PhD
Exploring the molecular mechanisms that drive cancer to uncover new opportunities for prevention, diagnosis, and treatment.
Population and Cancer Prevention
Program Leaders: Gregory S. Cooper, MD, and Fredrick Schumacher, PhD, MPH
Addressing the factors that shape cancer risk, access to care, and outcomes to improve health across all populations.